RedHill Biopharma Ltd. announced the appointment of Mr. Rick D. Scruggs to its Board of Directors, effective January 1, 2016. With over 25 years of experience in the pharmaceutical industry, Mr. Scruggs brings extensive knowledge in commercial operations and business development. He most recently served as Executive Vice President of Business Development at Salix Pharmaceuticals Ltd. (“Salix”), up to its acquisition by Valeant Pharmaceuticals International earlier this year.